IRVINE, Calif. , Oct. 24, 2024 /PRNewswire/ -- InMode Ltd.
(Nasdaq: INMD ), a leading global provider of innovative medical technologies, has been granted a preliminary injunction by the U.S. District Court for the Central District of California in a lawsuit filed against sellers identified to be the source of unlawful counterfeit sales of Morpheus8 radiofrequency devices and cartridge accessories.
On September 3, 2024 , the Honorable Michael Fitzgerald of the U.S. District Court for the Central District of California issued the order granting InMode's motion for a preliminary injunction.
InMode's large-scale action against these illegitimate sellers also warranted a Temporary Restraining Order (TRO), which was granted due to strong supporting evidence that it is within the public interest to protect InMode's trademarks and prevent the sale of counterfeit products, particularly in this case, where Defendants' counterfeit Morpheus8 products could be sold to unsuspecting third parties for use in medical procedures. As a result, a court-ordered preliminary injunction has been issued, freezing various assets, and account listings of all sellers involved in the sale of the aforementioned counterfeit goods. "InMode has zero tolerance for dishonest business practices and considers the safety of the public its number one priority," said Moshe Mizrahy , CEO of InMode.
"We will take necessary action with online platforms and sellers participating in the irresponsible use, sale or distr.
